21 news items
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LFCR
22 May 24
to the Company's previously-announced offer letter with Mr. Josephs, and as a material inducement to Mr. Josephs joining Lifecore as President and Chief
Lifecore Biomedical Completes Incremental Liquidity Initiatives
LFCR
16 May 24
. All forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially, including such factors
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
LFCR
15 May 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
LFCR
13 May 24
allegations that Lifecore Biomedical may have issued materially misleading business information to the investing public
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
LFCR
11 May 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business information
qu7b7
LFCR
7 May 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business
ssjrn19afff6soe47ggnofsjg483wajt83y0uq8ke9d602v4dgdvua4w1
LFCR
5 May 24
allegations that Lifecore Biomedical may have issued materially misleading business information to the investing public
uulur9c4jbgclzpi5p3gz3hj04c4c7x
LFCR
4 May 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business information
051aiev4nztz7akpaznfbifiu0nx5sxyzckbaw94sd5c4ma0 3svwq
LFCR
30 Apr 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business
r08vwmaucp39fh8 4k4m4ant413
LFCR
29 Apr 24
have issued materially misleading business information to the investing public
zdpsl xcb3z0kq
LFCR
25 Apr 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business
j09b12t5rvasgm2air34csz4thf2ycqm3882pz0h2xrp2r
LFCR
20 Apr 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business
bpjer05nfx 0s74si2dvbjjldb60f8umfeucfr10eblyssd2vnop8ibio
LFCR
19 Apr 24
allegations that Lifecore Biomedical may have issued materially misleading business information to the investing public
nfb8iir51hi71gzo1t9d6vck2f
LFCR
19 Apr 24
and uncertainties that could cause actual results to differ materially, including such factors among others, as the Company's ability to respond
fk2t5flvka7vr5mn8642sk36utvmroobc0dtye02uovi8745p3o7sg
LFCR
15 Apr 24
(NASDAQ:LFCR, LNDC))) resulting from allegations that Lifecore Biomedical may have issued materially misleading business
0m521a68dh341ajcf8yrvkuc88uwmnie8ltgx
LFCR
12 Apr 24
allegations that Lifecore Biomedical may have issued materially misleading business information to the investing public
b54za6lln4c2www86b0w7r1x u4a72f4wk2cpz
LFCR
11 Apr 24
materially misleading business information to the investing public.
SO
nchsa t9meshcyosz70e8h
LFCR
1 Apr 24
differ materially from these preliminary estimates, including as a result of audit adjustments and other developments that may arise between now
ghw1pzsdnu0a2g7dff7aor9i16blipkkvoj7e jcym8nqvhr
LFCR
26 Mar 24
results to differ materially, including such factors among others, as the outcome of any evaluation of the Company's strategic alternatives or any
5s7mdhtd mi9x5oso
LFCR
20 Mar 24
by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may